Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, incl...

Full description

Bibliographic Details
Main Authors: Manfredi Rizzo, Dimitri P. Mikhailidis, Esma R. Isenovic, Dragana Nikolic, Niki Katsiki, Giuseppe Montalto
Format: Article
Language:English
Published: MDPI AG 2013-03-01
Series:Nutrients
Subjects:
lipoproteins
small dense low density lipoprotein
obesity
metabolic syndrome
obesity treatment
anti-obesity drugs
lipid-lowering drugs
Online Access:http://www.mdpi.com/2072-6643/5/3/928

Internet

http://www.mdpi.com/2072-6643/5/3/928

Similar Items